Dr. Harkless obtained a Bachelor of Science degree from Case Western Reserve University
in Applied Physics before obtaining a Ph.D. in Experimental Physics from the University of
Florida in 1990. His dissertation studied structural phase transitions in novel materials
such as binary polymers as observed using innovative time-resolved x-ray scattering
Dr. Harkless has over 30 years of experience in executive management, sensor
development, algorithm engineering, noise reduction, weak signal detection, and
interpretation of physical phenomena. During that time Dr. Harkless had the privilege of
developing novel signal detection and parameter estimation techniques for mission critical
applications in both the US Defense and commercial domains.
As a Department Manager for Areté Associates, Dr. Harkless led the company’s efforts to
adapt physics-based defense technology for use in commercial industries. One such
application was adaptation of simulation software developed in support of the Navy for use
in the entertainment industry. The resulting special effects software generated high
fidelity ocean, sky, and cloud animations used in several major motion pictures such as
Titanic and Waterworld.
Fingerprint identification was another adaptation of defense technology led by Dr. Harkless
that resulted in a commercial spin-off. As Vice President of Engineering with Bioscrypt, Inc.
Dr. Harkless led their image processing initiatives emphasizing noise reduction, image
enhancement, pattern recognition, and real-time computing. Dr. Harkless also drove
business development efforts culminating in the adoption of the core fingerprint
authentication technology by Apple.
After returning to Areté Associates as Executive Vice President, Dr. Harkless led a team of
almost 200 scientists and engineers investigating novel approaches to real-time video
processing, geo-registration, moving target identification, and target detection. He also
investigated signal characterization and detection in the field of fluorescence-based
biological contaminant detection.
At present, Dr. Harkless serves as President and CEO of Radcal Corporation, a premier
provider of quality assurance instruments for diagnostic x-ray imaging systems. Dr.
Harkless leads a highly skilled team in developing and delivering innovative instruments to
meet the ever changing demands of today’s x-ray imaging systems.